Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTP Block in Cardiac Surgery
NCT03128346Unknown
- Sponsor
- Western University
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Western University. Primary endpoint: Narcotic requirements equivalents at 48 hours. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03128346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03128346.